Vitiligo, a significant dermatologic challenge affecting 0.5 to 2% of the global population. Despite various existing medical approaches, current vitiligo treatments are still far from optimal.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Guartile grading scale
Timeframe: 2 months
analysis of Jak3 expression in vitiligo lesions
Timeframe: 2months